BIOCON BIOLOGICS LIMITED

Biocon Biologics Limited is primarily a manufacturer.

Company Introduction:

Biocon Biologics Limited is a leading global biopharmaceutical company headquartered in Bengaluru, India. It is a subsidiary of Biocon Ltd., a pioneer in the biotechnology sector. Biocon Biologics is dedicated to developing, manufacturing, and commercializing high-quality, affordable biosimilars and novel biologics for patients worldwide. The company has extensive research and development capabilities and operates state-of-the-art, large-scale manufacturing facilities that comply with global regulatory standards. Their product portfolio primarily focuses on therapeutic areas such as diabetes, oncology, and immunology, offering biosimilar insulins, monoclonal antibodies, and other complex biologics. Biocon Biologics is committed to making a significant impact on global healthcare by increasing access to life-saving medicines and transforming patient lives.

Here are the products manufactured or marketed by Biocon Biologics Limited of India:

* Insulin Glargine

* Insulin Aspart

* Insulin Lispro

* Biosimilar Trastuzumab

* Biosimilar Pegfilgrastim

* Biosimilar Bevacizumab

* Adalimumab

* Etanercept